Login| Sign Up| Help| Contact|

Patent Searching and Data


Matches 1 - 50 out of 32,126

Document Document Title
WO/2020/188437A1
The present invention relates to compounds with a 5-(2-nitroethyI)-2,4,6- triaminopyrimidine structure, derivatised at the 1 position on the ethylene chain with heteroaromatic or phenyl-benzylether rings. The invention also relates to th...  
WO/2020/188049A1
The present invention relates to compounds of the general formula (I): (I), wherein V, W, M, R, R and Y have the designations cited below, or a pharmaceutically or veterinary acceptable salt, hydrate or solvate thereof, and to processes ...  
WO/2020/182929A1
The present invention relates to compounds of formula (I): Formula (I) wherein the variables are defined as in claim 1, to compositions comprising at least one of said compounds and at least one agriculturally suitable auxiliary, to the ...  
WO/2020/182070A1
Disclosed by the present invention are a compound using triarylamine that contains pyrene or azapyrene as a core and an application thereof. The structure of the organic compound provided by the present invention is as shown in general f...  
WO/2020/184906A1
The present invention relates to a novel organic light emitting compound and an organic electroluminescent device using same and, more particularly, to a compound having excellent thermal stability, electrochemical stability, light-emitt...  
WO/2020/185038A1
The present invention provides: a novel compound represented by chemical formula 1, which is contained in an organic layer of an organic light emitting device and can bring improved efficiency, low driving voltage, and/or improved servic...  
WO/2020/185026A1
The present specification relates to a compound represented by chemical formula 1 and an organic light emitting diode comprising same.  
WO/2020/177752A1
The present invention relates to the technical field of medicine, and specifically disclosed thereby are a 1,2,4-triazole compound represented by formula (I) and a physiologically acceptable salt thereof, a preparation method for the com...  
WO/2020/177587A1
The present invention falls within the field of biological medicine, and specifically relates to a method for preventing, alleviating and/or treating fatty liver disease and/or steatohepatitis. The method compirses administering, to an i...  
WO/2020/176643A1
The present disclosure provides heteroaryl compounds and pharmaceutically acceptable salts thereof useful as adjuvants and their use in pharmaceutical compositions such as vaccines. Further disclosed is the use of heteroaryl compounds an...  
WO/2020/174058A1
The invention relates to a method for producing quinoxalines by condensation of optionally substituted o-phenylenediamine with a diketone in accordance with the following reaction mechanism (mechanism 4) wherein: R1, R2 and R3 each indep...  
WO/2020/175961A1
The present specification relates to a compound of chemical formula 1 and an organic light emitting device comprising same.  
WO/2020/171531A1
The present specification relates to a compound represented by chemical formula 1 and an organic light emitting device comprising same.  
WO/2020/171532A1
The present specification relates to a compound represented by chemical formula 1 and an organic light-emitting element comprising same.  
WO/2020/170022A1
This invention relates to the novel potentially therapeutic compounds that contain l-acyl derivatives of aziridine-2-carboxamide and their analogues with the anticancer and/or antiproliferative, and/or antimetastatic properties and/or th...  
WO/2020/171530A1
The present specification relates to a compound represented by chemical formula 1 and an organic light-emitting device comprising same.  
WO/2020/169509A1
The invention relates to 4-(4-trifluormethyl-6-cycloropylpyrazolyl)pyrimidines of general formula (I) and to their agrochemically acceptable salts, and to the use thereof in the field of plant protection.  
WO/2020/170202A1
A TNIK and/or MAP4K4 kinase inhibitor can include: Formula A, derivative, prodrug, salt, stereoisomer, tautomer polymorph, or solvate thereof, or having chirality at any chiral center, Formula A; wherein: ring 1 is an aromatic ring with ...  
WO/2020/169526A1
A compound of formula (I), wherein the substituents are as defined in claim 1, and the agrochemically acceptable salts, stereoisomers, enantiomers, tautomers and N-oxides of those compounds, can be used as insecticides.  
WO/2020/168149A1
Disclosed are compounds of Formula (I): or a stereoisomer, a tautomer, or a pharmaceutically acceptable salt or solvate thereof, wherein Q is: (i) halo, cyano, hydroxyl, NRxRx, C(O)OH, C(O)NH2, C1-6 alkyl substituted with zero to 6 R1a, ...  
WO/2020/166875A1
The present invention provides a novel compound and an organic light emitting device using same.  
WO/2020/166874A1
The present invention provides a novel compound and an organic light-emitting diode using same.  
WO/2020/166873A1
The present invention provides a novel compound and an organic light emitting device comprising same.  
WO/2020/162471A1
Provided is a novel compound capable of inhibiting a bond between a BET protein and acetylated lysine. The present invention relates to, for example, the compound represented by general formula (1) or a salt thereof, and a pharmaceutic...  
WO/2020/162703A1
The present invention provides a novel heterocyclic compound and an organic light emitting device using same.  
WO/2020/163554A1
Provided herein are novel ligands and pharmaceutical compositions thereof which modulate IL-17A. Also provided are methods for preparing the IL-17A modulators. Such compounds may be useful in the treatment and/or prevention of, for examp...  
WO/2020/162612A1
The present invention provides a compound represented by formula (I'), which has an inhibitory effect on an enzyme that produces 20-HETE, or a pharmaceutically acceptable salt of the compound. (In formula (I'), ring D represents one of t...  
WO/2020/159279A1
The present specification provides a compound represented by chemical formula 1 and an organic light-emitting element comprising same.  
WO/2020/159333A1
The present specification provides a compound of chemical formula 1 and an organic light emitting device comprising same.  
WO/2020/156363A1
The present application discloses an immunomodulator, and specifically discloses a compound depicted by formula (I), or a stereoisomer thereof, or a pharmaceutically acceptable salt thereof. The compound provided in the present applicati...  
WO/2020/159340A1
The present specification provides a compound of chemical formula 1 and an organic light emitting device comprising same.  
WO/2020/157644A1
The present invention provides process for the preparation of amorphous canagliflozin substantially free of hydroperoxide impurity. The present invention also provides pharmaceutical compositions comprising amorphous canagliflozin having...  
WO/2020/157204A1
The present invention relates to a composition, in particular to an organic semiconductor layer comprising a composition, suitable for use as an organic semiconductor layer for electronic devices, and a method of manufacturing the same, ...  
WO/2020/160202A1
Disclosed are compounds of Formula 1, including all stereoisomers, A-oxides, and salts thereof, wherein A is selected from and X, Q1, Q2, Q3, Q4, R, R1, R2, R3, R4 and n are as defined in the disclosure. Also disclosed are compositions c...  
WO/2020/159332A1
The present specification provides a compound of chemical formula 1 and an organic light emitting device comprising same.  
WO/2020/159019A1
The present invention relates to a novel organic light-emitting compound and an organic electroluminescent device using same and, more specifically, to a compound having excellent thermal stability, electrochemical stability, light-emitt...  
WO/2020/159337A1
The present specification provides a compound of chemical formula 1 and an organic light emitting device comprising same.  
WO/2020/160151A1
A compound having one of formula (1), formula (2), formula (3) and formula (4) or a pharmacologically acceptable salt thereof.  
WO/2020/159343A1
The present invention relates to an amide derivative compound or a pharmaceutically acceptable salt thereof, which can be beneficially used in the treatment or prevention of Middle East Respiratory Syndrome (MERS). In addition, the prese...  
WO/2020/159334A1
The present specification provides a compound expressed by chemical formula 1, and an organic light-emitting element comprising same.  
WO/2020/159266A1
The present invention relates to a compound represented by chemical formula 1, an organic optoelectronic device, and a display device.  
WO/2020/159336A1
The present specification provides: a compound of chemical formula 1; and an organic light-emitting device including same.  
WO/2020/159335A1
The present specification provides a compound of chemical formula 1 and an organic light emitting diode comprising same.  
WO/2020/154243A1
The present disclosure relates generally to alkyne containing pharmaceutical agents, and in particular, to phenylethynyl-thiophene based compounds. More particularly, the present disclosure provides a class of compounds that can inhibit ...  
WO/2020/153414A1
The purpose of the present invention is to provide a heterocyclic compound that can have an antagonist activity against an NMDA receptor including an NR2B subunit and is thus expected to be useful as a prophylactic or therapeutic agent f...  
WO/2020/154499A1
In one aspect, compounds of Formula AA, or a pharmaceutically acceptable salt thereof, are featured: (Formula AA) or a pharmaceutically acceptable salt thereof, wherein the variables shown in Formula A can be as defined anywhere herein.  
WO/2020/152067A1
Compounds of the formula (I): Q1-Q2-Q3, in which Q1, Q2 and Q3 have the meanings indicated in Claim 1, degrade target proteins, and can be employed, inter alia, for the treatment of diseases such as cancer, multiple sclerosis, cardiovasc...  
WO/2020/153713A1
The present specification provides a compound expressed by chemical formula 1, and an organic light-emitting element comprising same.  
WO/2020/127259A3
The present application concerns compounds for use in electronic devices, processes for preparing the compounds, and electronic devices comprising the compounds.  
WO/2020/153652A1
The present specification relates to: a compound represented by chemical formula 1; and an organic light emitting element including same.  

Matches 1 - 50 out of 32,126